The Burden of Human Parechoviruses Among Children in Oman: A retrospective study

Aws Al-Farsi1, Zaid Alhinai1, Fatma Ba Alawi2

  • 1College of Medicine and Health Sciences, Sultan Qaboos University, Sultan Qaboos University Hospital, Muscat, Oman.

Insights

Human parechoviruses (HPeVs) infections in Omani children are common, often occurring with other viruses and typically resulting in full recovery. Further follow-up for neurological outcomes is needed.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Human parechoviruses (HPeVs) are a group of viruses that can cause illness in children.
  • Understanding the epidemiology and clinical presentation of HPeV infections is crucial for effective management.

Purpose of the Study:

  • To evaluate the burden, clinical and laboratory features, and outcomes of HPeV infections in children in Oman.
  • To describe the demographic characteristics and common comorbidities of affected children.

Main Methods:

  • A retrospective study was conducted analyzing data from children (<18 years) with molecularly confirmed HPeV infection.
  • Data were collected from medical records at Sultan Qaboos University Hospital, Muscat, Oman (January 2017-December 2019).
  • Demographics, clinical presentation, laboratory findings, management, and outcomes were analyzed.

Main Results:

  • HPeV was detected in 61 children, predominantly males (72%), with a median age of nine months.
  • Most infections occurred year-round, with 84% of patients having co-infections and 79% requiring hospitalization.
  • Fever and cough were common symptoms; lower respiratory tract infections were frequent, while meningitis and gastroenteritis were rare. All patients recovered fully.

Conclusions:

  • HPeV infections in Omani children lack clear seasonality, often present with viral co-infections, and generally have favorable outcomes.
  • While no mortalities were observed, a lack of thorough neurological outcome follow-up was noted.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
714
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240